Using a tablet PC and the Apple phone, assiTek says larger screens can be helpful to science and sites. more...

A presentation from the 2008 Clinical Trials Congress on how to think about improving strategic relationships between sponsors. more...

With 20 employees, Akaza Research says some customers like not being locked into one supplier. more...

Reflections on the power of narrative and the industry’s wobbly reputation. more...

The ramifications of a deal that may never come to pass. more...

Stephen Spielberg has stepped down as dean of the Dartmouth Medical School to help the Boston-based Institute for Pediatric Innovation. more...

Rhonda Facile of CDISC talks about the CDASH effort to standardize case report forms. The first public release is due soon. more...

A former CRA in Sydney, Australia, has launched a portal that she hopes will be many things to many people in the clinical trials industry down under. more...

A biostatician with deep NIH and FDA ties talks about general guidelines for changing primary end points. Plus, the M-word. more...

The San Francisco firm discusses the difficulty of some of its projects and why it likes more experienced employees. more...

Discussing its recent quarterly earnings, Parexel is optimistic on all fronts. more...

Miriam Shuchman, who wrote the NEJM’s recent analysis of CROs, discusses the intersection of medical journals and the drug industry. more...

Believe it or not, and you might not, the FDA developed and approved two drugs at the end of a long and difficult year. more...

Integrated Clinical Trial Services has come up with a nifty way to increase enrollment: Hollywood-worthy, modular DVDs. more...

Sponsors are abuzz about site relationship management (SRM). In the first installment of our series, Wyeth describes its efforts to become the sponsor of choice. more...

Sponsors are worrying about investigative sites demanding trial “startup” fees. more...